InStride Health raised $26 million from healthcare investors including .406 Ventures, Valtruis and Mass General Brigham Ventures.
The technology-enhanced mental health treatment platform formally launched this week for children and adolescents struggling with moderate to severe anxiety and OCD.
McLean Hospital, part of Mass General Brigham, is providing a range of advisory services to further InStride’s growth. Read more.
